{"protocolSection": {"identificationModule": {"nctId": "NCT01278030", "orgStudyIdInfo": {"id": "CRD 534"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates", "officialTitle": "Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates (ENVISION)", "acronym": "ENVISION"}, "statusModule": {"statusVerifiedDate": "2019-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2010-08"}, "primaryCompletionDateStruct": {"date": "2012-06", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-01-12", "studyFirstSubmitQcDate": "2011-01-13", "studyFirstPostDateStruct": {"date": "2011-01-17", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2013-06-04", "resultsFirstSubmitQcDate": "2013-10-21", "resultsFirstPostDateStruct": {"date": "2013-12-09", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2019-02-01", "lastUpdatePostDateStruct": {"date": "2019-02-19", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to demonstrate that cardiac resynchronization therapy (CRT) responder rate can be improved by 3-dimensional (3D) echo-guided left ventricular (LV) lead placement compared to traditional LV lead placement."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 78, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Control group", "type": "NO_INTERVENTION", "description": "Patients will be implanted according to the standard of care with the LV lead in the traditional LV lead position."}, {"label": "3D echo-guided LV lead placement group", "type": "EXPERIMENTAL", "description": "Information about left ventricular mechanical dyssynchrony and the location of the site of latest mechanical activation based on Real-Time 3-Dimensional Echocardiography (RT3DE) will be available to the physician at the time of implant. This location will be used as the target for optimal LV lead placement.", "interventionNames": ["Procedure: 3D echo-guided LV lead placement"]}], "interventions": [{"type": "PROCEDURE", "name": "3D echo-guided LV lead placement", "description": "Information about left ventricular mechanical dyssynchrony and the location of the site of latest mechanical activation based on RT3DE will be available to the physician from the core lab analysis. This location will be used as the target for optimal LV lead placement.", "armGroupLabels": ["3D echo-guided LV lead placement group"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Responder Rate", "description": "The responder rate is defined as the proportion of patients with reduction in end systolic volume greater than or equal to 15%. The primary endpoint is the responder rate.", "timeFrame": "At 6 month follow-up"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients will be implanted with an FDA approved St. Jude Medical CRT-D device (i.e. PROMOTE\u00ae or newer devices with similar functionality)\n* Patients will have an approved indication per American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for implantation of a CRT-D\n* Patients will receive a new implant or an upgrade from an existing pacemaker or Implantable Cardiovertor Defibrillator with no prior Left Ventricular lead placement\n* Patients must be in sinus rhythm at the time of enrollment visit and baseline measurements\n\nExclusion Criteria:\n\n* Persistent or permanent atrial fibrillation\n* Heart transplantation\n* Recent myocardial infarction (\\< 90 days)\n* Contra-indication to contrast agent\n* Are less than 18 years of age\n* Are pregnant\n* Are currently participating in a clinical investigation that includes an active treatment arm\n* Have a life expectancy of less than 6 months", "healthyVolunteers": false, "sex": "ALL", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "The Heart Group", "city": "Nashville", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "3D Echo-guided LV Lead Placement", "description": "The location of the site of latest mechanical activation based on 3-D Echo will be available to the physician from the core lab analysis. This location will be used as the target for optimal Left Ventricular lead placement."}, {"id": "FG001", "title": "Control", "description": "Patients will be implanted according to the standard of care with the Left Ventricular lead in the traditional Left Ventricular lead position."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "43"}, {"groupId": "FG001", "numSubjects": "35"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "35"}, {"groupId": "FG001", "numSubjects": "31"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "4"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "4"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "3D Echo-guided LV Lead Placement", "description": "The location of the site of latest mechanical activation based on 3-D Echo will be available to the physician from the core lab analysis. This location will be used as the target for optimal Left Ventricular lead placement."}, {"id": "BG001", "title": "Control", "description": "Patients will be implanted according to the standard of care with the Left Ventricular lead in the traditional Left Ventricular lead position."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "35"}, {"groupId": "BG002", "value": "78"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "13"}, {"groupId": "BG002", "value": "31"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "22"}, {"groupId": "BG002", "value": "47"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "67", "spread": "13"}, {"groupId": "BG001", "value": "67", "spread": "11"}, {"groupId": "BG002", "value": "67", "spread": "12"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "24"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "28"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "54"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "35"}, {"groupId": "BG002", "value": "78"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Responder Rate", "description": "The responder rate is defined as the proportion of patients with reduction in end systolic volume greater than or equal to 15%. The primary endpoint is the responder rate.", "populationDescription": "Patients who completed the 6 month follow-up with implant 3D echo data.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "At 6 month follow-up", "groups": [{"id": "OG000", "title": "3D Echo-guided LV Lead Placement", "description": "The location of the site of latest mechanical activation based on 3-D Echo will be available to the physician from the core lab analysis. This location will be used as the target for optimal Left Ventricular lead placement."}, {"id": "OG001", "title": "Control", "description": "Patients will be implanted according to the standard of care with the Left Ventricular lead in the traditional Left Ventricular lead position."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "67"}, {"groupId": "OG001", "value": "60"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "timeFrame": "6 months", "eventGroups": [{"id": "EG000", "title": "3D Echo-guided LV Lead Placement", "description": "The location of the site of latest mechanical activation based on 3-D Echo will be available to the physician from the core lab analysis. This location will be used as the target for optimal Left Ventricular lead placement.", "seriousNumAffected": 0, "seriousNumAtRisk": 43, "otherNumAffected": 1, "otherNumAtRisk": 43}, {"id": "EG001", "title": "Control", "description": "Patients will be implanted according to the standard of care with the Left Ventricular lead in the traditional Left Ventricular lead position.", "seriousNumAffected": 0, "seriousNumAtRisk": 35, "otherNumAffected": 1, "otherNumAtRisk": 35}], "otherEvents": [{"term": "Infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 43}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 35}]}, {"term": "Pericardial Effusion", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 43}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 35}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "John Gill", "organization": "St. Jude Medical", "email": "jgill@sjm.com", "phone": "818-493-2609"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}